Document Detail


Emollient for maintenance therapy after topical corticotherapy in mild psoriasis.
MedLine Citation:
PMID:  19453736     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Emollients or moisturizers can act as an important adjunctive therapy of topical treatment in psoriatic patients. However, the interest of emollients has never been clearly demonstrated; i.e. are they able to improve topical treatment efficacy and/or maintain continuous remission of the disease? The aim of this study was to evaluate the effect of an emollient on patients with mild plaque psoriasis during and after standard local corticosteroid therapy. Results showed that the use of an emollient can limit relapses after the end of corticotherapy, and maintain the improvement obtained after 1 month corticotherapy at clinical level (physician global assessment) and skin dryness.
Authors:
S Seit?; A Khemis; A Rougier; J P Ortonne
Related Documents :
18201356 - A comparative study of different treatment frequencies of psoralen and ultraviolet a in...
17658996 - Narrowband uvb therapy for vitiligo: does the repigmentation last?
6445816 - Clinical evaluation of a new erythromycin solution for acne vulgaris.
8646866 - Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropio...
19467406 - The incidence and management of siaolocele after parotidectomy.
3438216 - Cerebral palsy spasticity. selective posterior rhizotomy.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Experimental dermatology     Volume:  18     ISSN:  1600-0625     ISO Abbreviation:  Exp. Dermatol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-12-16     Completed Date:  2010-05-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9301549     Medline TA:  Exp Dermatol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  1076-8     Citation Subset:  IM    
Affiliation:
La Roche-Posay Pharmaceutical Laboratories, 110 Avenue Henri Barbusse, 92602 Asni?res Cedex, France. sseite@dca.loreal.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adrenal Cortex Hormones / administration & dosage,  therapeutic use*
Drug Therapy, Combination
Emollients / administration & dosage,  therapeutic use*
Humans
Psoriasis / diagnosis,  drug therapy*,  pathology
Quality of Life
Recurrence / prevention & control
Severity of Illness Index
Skin / drug effects,  pathology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Emollients

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contrasting thoughts about deceptive orchids: a response to sobel and randle.
Next Document:  Amoebic grazing of freshwater Synechococcus strains rich in phycocyanin.